Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
FURA-2 (AC166)
Cat.#: ASSD-166
Specifications
Description FURA-2 is a widely used UV light-excitable, ratiometric calcium indicator that is used for ratio-imaging microscopy to measure intracellular calcium. Membrane impermeable which can be loaded into cells by microinjection, electroporation or scrape loading. Size 1 mg Molecule Weight 831.99 Molecular formula C29H22N3O14K5 CAS Number 113694-64-7 PubChem identifier 341120321 Purity >90% Excitation 363 nm Emission 512 nm Storage Store at -20° C Shipping Shipped at 4°C Important This compound is light-sensitive. We strongly recommend storing this product, no matter the solid material and any solutions, in the dark and away from light. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-201 Fluoresceinamine Hydrochloride Isomer 1 (AC201) 2 g inquiry ASSD-169 Calcium Ionophore A23187 (AC169) 1mg, 5mg, 10 mg inquiry ASSD-159 Erythrosin B (AC159) 1g, 5g inquiry ASSD-221 Antifade Fluorescence Mounting Medium with DAPI (hard set) (AC221) 10 mL inquiry ASSD-120 Fluorescent adenosine antagonist [XAC] (AC120) 500 μg inquiry ASSD-102 DAPI (AC102) 10 mg, 50 mg inquiry ASSD-191 Fluorescein 6-Isothiocyanate, Isomer 2, 95% (AC191) 100 mg inquiry ASSD-149 D-Luciferin sodium salt (AC149) 10 mg, 50 mg, 100 mg inquiry ASSD-130 Calcein-AM (AC130) 1 mg inquiry ASSD-207 NBD-X acid (AC207) 1 g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket